BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7676713)

  • 1. Hepatolithiasis associated with cholangiocarcinoma.
    Kubo S; Kinoshita H; Hirohashi K; Hamba H
    World J Surg; 1995; 19(4):637-41. PubMed ID: 7676713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.
    Kim YT; Byun JS; Kim J; Jang YH; Lee WJ; Ryu JK; Kim SW; Yoon YB; Kim CY
    Hepatogastroenterology; 2003; 50(49):8-12. PubMed ID: 12629979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries.
    Lesurtel M; Regimbeau JM; Farges O; Colombat M; Sauvanet A; Belghiti J
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1025-7. PubMed ID: 12352225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.
    Kim HJ; Kim JS; Suh SJ; Lee BJ; Park JJ; Lee HS; Kim CD; Bak YT
    World J Surg; 2015 Jun; 39(6):1537-42. PubMed ID: 25648078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and surgical treatment of intrahepatic hepatolithiasis associated cholangiocarcinoma.
    Han SL; Zhou HZ; Cheng J; Lan SH; Zhang PC; Chen ZJ; Zeng QQ
    Asian J Surg; 2009 Jan; 32(1):1-6. PubMed ID: 19321395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma in a 24-year-old woman with hepatolithiasis.
    Leelawat K; Wannaprasert J
    J Med Assoc Thai; 2009 Jul; 92(7):983-6. PubMed ID: 19626820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late development of cholangiocarcinoma after the treatment of hepatolithiasis.
    Chijiiwa K; Ichimiya H; Kuroki S; Koga A; Nakayama F
    Surg Gynecol Obstet; 1993 Sep; 177(3):279-82. PubMed ID: 8395085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portography in decision-making about indications for liver resection in hepatolithiasis.
    Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H
    Osaka City Med J; 1995 Jul; 41(1):1-10. PubMed ID: 7675422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years.
    Suzuki Y; Mori T; Momose H; Matsuki R; Kogure M; Abe N; Isayama H; Tazuma S; Tanaka A; Takikawa H; Sakamoto Y
    J Gastroenterol; 2022 May; 57(5):387-395. PubMed ID: 35357571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocellular carcinoma depending on the kind of intrahepatic calculi in patients with hepatolithiasis.
    Chijiiwa K; Ohtani K; Noshiro H; Yamasaki T; Shimizu S; Yamaguchi K; Tanaka M
    Hepatogastroenterology; 2002; 49(43):96-9. PubMed ID: 11941992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of hepatic resection for hepatolithiasis.
    Uenishi T; Hamba H; Takemura S; Oba K; Ogawa M; Yamamoto T; Tanaka S; Kubo S
    Am J Surg; 2009 Aug; 198(2):199-202. PubMed ID: 19249730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
    Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma presenting as pyogenic liver abscess: is its outcome influenced by concomitant hepatolithiasis?
    Jan YY; Yeh TS; Chen MF
    Am J Gastroenterol; 1998 Feb; 93(2):253-5. PubMed ID: 9468254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study.
    Liu ZY; Zhou YM; Shi LH; Yin ZF
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):626-31. PubMed ID: 22146627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
    Chen CY; Shiesh SC; Tsao HC; Lin XZ
    Hepatogastroenterology; 2002; 49(45):616-20. PubMed ID: 12063953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
    Yamanaka N; Okamoto E; Ando T; Oriyama T; Fujimoto J; Furukawa K; Tanaka T; Tanaka W; Nishigami T
    Cancer; 1995 Dec; 76(12):2449-56. PubMed ID: 8625070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years.
    Suzuki Y; Mori T; Yokoyama M; Nakazato T; Abe N; Nakanuma Y; Tsubouchi H; Sugiyama M
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):617-22. PubMed ID: 24824191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
    Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
    Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyogenic liver abscess related to intrahepatic bile duct stones: Difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma.
    Shi SH; Feng XN; Wang ZY; Sun K; Xu JF; Kong HS; Zheng SS
    J Gastroenterol Hepatol; 2018 May; 33(5):1092-1099. PubMed ID: 28984386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin-producing cholangiocarcinoma: clinical experience of 24 cases in 16 years.
    Kuo CM; Changchien CS; Wu KL; Chuah SK; Chiu KW; Chiu YC; Chou YP; Kuo CH
    Scand J Gastroenterol; 2005 Apr; 40(4):455-9. PubMed ID: 16028441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.